Evidence map›Paper›PMID 30616543›Full record

ArticleMolecular medicine (Cambridge, Mass.)2019

Loss of intestinal sympathetic innervation elicits an innate immune driven colitis.

Rose A Willemze, Olaf Welting, Patricia van Hamersveld, Caroline Verseijden, Laurens E Nijhuis, Francisca W Hilbers, Sybren L Meijer, Balthasar A Heesters, Joost H A Folgering, Harold Darwinkel and 5 more

Open access · goldAbstract read
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Rose A WillemzeAmsterdam UMC, Tytgat Institute for Liver and Intestinal Research, University of Amsterdam, Meibergdreef 69, 1105 BK, Amsterdam, The Netherlands. r.a.willemze@amc.uva.nl.ORCID 0000-0002-9836-7358
Olaf WeltingAmsterdam UMC, Tytgat Institute for Liver and Intestinal Research, University of Amsterdam, Meibergdreef 69, 1105 BK, Amsterdam, The Netherlands.
Patricia van HamersveldAmsterdam UMC, Tytgat Institute for Liver and Intestinal Research, University of Amsterdam, Meibergdreef 69, 1105 BK, Amsterdam, The Netherlands.
Caroline VerseijdenAmsterdam UMC, Tytgat Institute for Liver and Intestinal Research, University of Amsterdam, Meibergdreef 69, 1105 BK, Amsterdam, The Netherlands.
Laurens E NijhuisAmsterdam UMC, Tytgat Institute for Liver and Intestinal Research, University of Amsterdam, Meibergdreef 69, 1105 BK, Amsterdam, The Netherlands.
Francisca W HilbersAmsterdam UMC, Tytgat Institute for Liver and Intestinal Research, University of Amsterdam, Meibergdreef 69, 1105 BK, Amsterdam, The Netherlands.
Sybren L MeijerAmsterdam UMC, Department of Pathology, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Balthasar A HeestersAmsterdam UMC, Department of Experimental Immunology, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Joost H A FolgeringCharles River Laboratories, Discovery, De Mudden 16, 9747 AW, Groningen, The Netherlands.
Harold DarwinkelCharles River Laboratories, Discovery, De Mudden 16, 9747 AW, Groningen, The Netherlands.
Philippe BlancouInstitute of Molecular and Cellular Pharmacology, Nice Sophia Antipolis University, 660 Route des Lucioles, 06560, Valbonne, France.
Margriet J VervoordeldonkGalvani Bioelectronics, Gunnels Wood Road, Stevenage, Hertfordshire, SG1, 2NY, UK.
Jurgen SeppenAmsterdam UMC, Tytgat Institute for Liver and Intestinal Research, University of Amsterdam, Meibergdreef 69, 1105 BK, Amsterdam, The Netherlands.
Sigrid E M HeinsbroekAmsterdam UMC, Tytgat Institute for Liver and Intestinal Research, University of Amsterdam, Meibergdreef 69, 1105 BK, Amsterdam, The Netherlands.
Wouter J de JongeAmsterdam UMC, Tytgat Institute for Liver and Intestinal Research, University of Amsterdam, Meibergdreef 69, 1105 BK, Amsterdam, The Netherlands. w.j.dejonge@amc.uva.nl.
Amsterdam University Medical Centers · NLCharles River Laboratories (Netherlands) · NLInstitut de Pharmacologie Moléculaire et Cellulaire · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBoth the parasympathetic and sympathetic nervous system exert control over innate immune responses. In inflammatory bowel disease, sympathetic innervation in intestinal mucosa is reduced. Our aim was to investigate the role of sympathetic innervation to the intestine on regulation of the innate immune responses.

methodsIn lipopolysaccharide (LPS)-stimulated macrophages, we evaluated the effect of adrenergic receptor activation on cytokine production and metabolic profile. In vivo, the effect of sympathetic denervation on mucosal innate immune responses using 6-hydroxydopamine (6-OHDA), or using surgical transection of the superior mesenteric nerve (sympathectomy) was tested in Rag1

resultsIn murine macrophages, adrenergic β2 receptor activation elicited a dose-dependent reduction of LPS-induced cytokines, reduced LPS-induced glycolysis and increased maximum respiration. Sympathectomy led to a significantly decreased norepinephrine concentration in intestinal tissue. Within 14 days after sympathectomy, mice developed clinical signs of colitis, colon oedema and excess colonic cytokine production. Both 6-OHDA and sympathectomy led to prominent goblet cell depletion and histological damage of colonic mucosa.

conclusionsWe conclude that the sympathetic nervous system plays a regulatory role in constraining innate immune cell reactivity towards microbial challenges, likely via the adrenergic β2 receptor.

Indexed as

Immunity, InnateImmunity, MucosalAdrenergic beta-2 Receptor AgonistsAlbuterolAnimalsCells, CulturedColitisColonCytokinesFemaleHumansIntestinal MucosaLipopolysaccharidesMacrophagesMaleMice, Inbred C57BLAdrenergic beta-2 Receptor AgonistsAlbuterolCytokinesLipopolysaccharidesOxidopamineAutonomic nervous systemColitisInflammatory bowel diseaseNorepinephrineSympathetic innervation

Identifiers

PMID30616543
PMCPMC6322236
OpenAlexW2919112117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.